InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the full record of transactions filed by Juvenescence Ltd. Director active across 2 companies, notably AgeX Therapeutics, Inc.. Aggregated, 2 reports have been published. Activity tracked since 14 March 2023. The latest transaction was disclosed on 6 June 2024 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条